Skip to main content

This job has expired

Finance Manager

Employer
Oxford BioMedica (UK) Limited
Location
Oxford
Salary
Competitive
Start date
28 Mar 2024
Closing date
26 Apr 2024

View more

Discipline
Finance / Administration, Finance
Hours
Full Time
Contract Type
Permanent
Experience Level
Experienced (non-manager)

Job Details

Job description:
 

We pride ourselves on our integrity. We do what is right for our employees, patients, and partners, and so can you.

 

We are currently recruiting for a Finance Manger to join the Finance team. The Finance Manager plays a central role within finance, with responsibility for the UK Revenue, COGS, Inventory, and Enterprise Resource Management (ERP) day to day maintenance and Group reporting support.  

Our Finance team provide financial reporting, control, and accountancy across the business.

 

Your responsibilities in this role would be:

 

  • Responsible for the supporting Overseas Group entities with their reporting including system integration reporting and resolving issues, intercompany eliminations and currency translations and support their Financial Reporting deliverables.
  • Support the UK revenue entries to ensure revenue recognition is accurate and in line with IFRS 15  
  • Review of the UK Cost of Goods Sold entries and Project Margin reviews supporting the team to ensure that correct project cost allocations, including timesheets are being made and supporting revenue recognition.
  • Support the following UK reporting areas: fixed assets, intangibles, IFRS 16 Lease accounting and dilapidation provisions including adjustments from overseas non IFRS entities.
  • Ensure a good understanding of our ERP system and related processes to take the role of ERP expert within the Finance Team.
  • Participate with the wider team in the preparation of documentation for the year end audit.

 

 

 


Profile description:

 

 

 

We are looking for:

 

 

 

  • Qualified ACA or ACCA qualification,
  • Proven experience as a qualified accountant working within finance or an accounting practice.
  • Strong technical experience including multi-currency Group Consolidations.
  • Good understanding of financial reporting and processes in a business environment
  • Good knowledge of ERP systems processes and transactions
  • Good Microsoft Office skills with advanced skills in MS Excel.
  • Strong communicator with the ability to build relationships cross functionally.
  • Previous supervisory and/or coaching and mentoring experience preferred.

  

 

About Us:

 

Oxford Biomedica is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

 

Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

 

 

What’s in it for you:

 

  • Highly competitive total reward packages
  • Wellbeing programmes
  • Development opportunities
  • Welcoming, friendly, supportive colleagues
  • A diverse and inclusive working environment
  • Our values are: Deliver Innovation, Be Inspiring and Have Integrity
  • State of the art laboratory and manufacturing facilities

 

We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment, and teamwork, and so can you.

 

Collaborate. Contribute. Change lives.

 


We offer:

 

 

 

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.  

 

 

 

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).  

 

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

Company

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.  

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).  

Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. 

Oxford Biomedica, a FTSE4Good constituent, is headquartered in Oxford, UK. It has locations across Oxfordshire, UK and near Boston, MA, US. Learn more at www.oxb.comwww.oxbsolutions.com, and follow us on LinkedInTwitter and YouTube

Life at Oxford Biomedica

We value everyone’s unique contribution, we appreciate everyone’s individuality, and every job matters.

Your contributions are recognised and appreciated. Your work-life balance matters. We recognise, develop and use your strengths. It’s a place where you are valued as a whole person, as an individual and as part of a team.

No matter who you are, or what you do, your work will make a significant difference.

We go the extra mile, every day, because we truly care. We work together as a team to achieve our life changing therapies. Our talented colleagues help to build other people’s futures, so can you. We empower each other to be our best.

We have access to like-minded scientists and engineers, working in the latest technologies.

Our community of experts create new life-saving cures. Shaping the business’ future through collaboration. Our people are on a continuous professional development journey aided by a thought-provoking environment. A place for experts to be stretched, and future experts to be nurtured. We inspire creativity and deliver great science, and so can you.

Our supportive culture invites talent, while creating future innovators.

We’ll give you a place where you can learn, grow and contribute to the future of cell and gene therapy. We create opportunities and invest in our people, promoting ongoing learning.  Our defined career pathways provide opportunities for everyone to achieve their career potential.  We make a difference, and so can you.

Company info
Website
Telephone
+44 (0) 1865 783 000
Location
Windrush Court
Transport Way
Oxford
OX4 6LT
GB

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Create alert